T1	p 54 64	infarction
T2	p 227 269	patients on thrombolytic therapy ( TLT ) .
T3	p 291 330	106 males with Q-MI entered the study .
T4	p 361 364	TLT
T5	p 369 389	neoton , 30 patients
T6	p 399 421	TLT with streptokinase
T7	p 435 448	, 29 patients
T8	p 1111 1122	dysfunction
T9	i 6 39	[ Neoton and thrombolytic therapy
T10	i 85 91	neoton
T11	i 239 267	thrombolytic therapy ( TLT )
T12	i 343 516	treatment without TLT and neoton , 30 patients received TLT with streptokinase preparations , 29 patients were given streptokinase preparations and neoton . Left ventricular
T13	i 551 567	echocardiography
T14	i 667 669	MI
T15	i 976 982	neoton
T16	i 1019 1031	Neoton given
T17	i 1035 1037	MI
T18	i 1047 1069	receiving TLT prevents
T19	o 149 166	systolic function
T20	o 174 188	left ventricle
T21	o 191 201	arrhythmia
T22	o 206 223	clinical symptoms
T23	o 500 534	Left ventricular systolic function
T24	o 694 741	arrest progression of left ventricular dilation
T25	o 760 773	hospital stay
T26	o 847 877	systolic and diastolic volumes
T27	o 885 889	left
T28	o 1085 1122	left ventricular systolic dysfunction